Clinical Trial Update: HRV Biofeedback for Brain Tumour Survivors [NA]

View source ↗

Summary

A clinical trial evaluating heart rate variability biofeedback for depression, anxiety, and sleep impairment in brain tumor survivors has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Neoplasms

Snippet

Sponsor: British Columbia Cancer Agency | Conditions: Depression, Anxiety | NA | Status: SUSPENDED